Form 8-K - Current report:
SEC Accession No. 0000875320-21-000012
Filing Date
2021-04-29
Accepted
2021-04-29 16:09:10
Documents
15
Period of Report
2021-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vrtx-20210429.htm   iXBRL 8-K 32892
2 EX-99.1 ex-991_q12021.htm EX-99.1 216908
  Complete submission text file 0000875320-21-000012.txt   412906

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20210429.xsd EX-101.SCH 2508
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20210429_cal.xml EX-101.CAL 795
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20210429_def.xml EX-101.DEF 1759
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20210429_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20210429_pre.xml EX-101.PRE 12731
8 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20210429_htm.xml XML 10599
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 21870596
SIC: 2834 Pharmaceutical Preparations